Skip to main content
AVTX logo
AVTX
(NASDAQ)
Avalo Therapeutics, Inc.
$17.76-- (--)
Loading... - Market loading

Avalo Therapeutics, Inc. (AVTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Avalo Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy
Based on 11 unique analysts
(12 total ratings in last 90 days)
High Confidence:1 Buy/Sell

Average Price Target

$44.90
152.82% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AVTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Thomas Smith
Leerink Partners
BuyInitiates
$38.00
Alec Stranahan
BofA Securities
BuyInitiates
$35.00
Stacy Ku
TD Cowen
BuyMaintains
-
Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$36.00 $39.00
Jason Butler
Citizens JMP
BuyMaintains
$62.00 $55.00
Robert Driscoll
Wedbush
BuyReiterates
$40.00 $34.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$40.00 $35.00
Joseph Catanzaro
Mizuho
BuyMaintains
$39.00 $45.00
Julian Harrison
BTIG
BuyMaintains
$58.00
Julian Harrison
BTIG
BuyMaintains
$58.00
Yasmeen Rahimi
Piper Sandler
BuyInitiates Coverage
$48.00 $60.00
Yatin Suneja
Guggenheim
BuyMaintains
$50.00

Frequently Asked Questions

What is the analyst consensus rating for AVTX?

The analyst consensus rating for AVTX is "Buy" based on 11 analyst recommendations.

What is the average price target for AVTX?

The average 12-month price target for AVTX is $44.90, representing an upside of 152.8% from the current price of $17.76.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.